| Schedule of basic and diluted earnings per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year ended
December 31, 2025 |
|
|
Year ended
December 31, 2024 |
|
|
Year ended
December 31, 2023 |
|
| |
|
|
719,063 |
|
|
|
477,521 |
|
|
|
396,955 |
|
Weighted average number of ordinary shares |
|
|
102,499,637 |
|
|
|
95,906,449 |
|
|
|
93,679,904 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year ended
December 31, 2025 |
|
|
Year ended
December 31, 2024 |
|
|
Year ended
December 31, 2023 |
|
| |
|
|
719,063 |
|
|
|
477,521 |
|
|
|
396,955 |
|
Weighted average number of ordinary shares (1) |
|
|
107,212,399 |
|
|
|
103,077,629 |
|
|
|
99,232,919 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
As of December 31, 2025, the Company has 104,299,705 outstanding shares that cannot exceed 106,078,535 shares. Likewise, in accordance with IFRS accounting standard the average number of ordinary shares with a potential dilutive effect amounts to 107,212,399. |
|